According to IMARC Group’s latest report, titled “Natural Killer Cells Therapeutics Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2022-2027”, the global natural killer cells therapeutics market reached a value of US$ 2.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027, exhibiting a CAGR of 15.65% during 2022-2027. Natural killer (NK) cells are large granular lymphocytes responsible for producing immunoregulatory cytokines. They are a type of white blood cells that act as a vital component of the human immune system. They contain small granules of special proteins such as proteases and perforin known as granzymes. NK cell therapeutics are developed through ex vivo pre-conditioning with cytokine or small molecular drugs and chimeric antigen receptor (CAR) NK. They aim at pathogenic antigens with cytotoxicity and reduce the risk of cytokine storms.
Request for a PDF sample of this report: https://www.imarcgroup.com/natural-killer-cells-therapeutics-market/requestsample
Natural Killer Cells Therapeutics Market Size/Drivers:
The global NK cells therapeutics market is primarily driven by their increasing utilization in various molecular and combination therapies for various treatments. They are used as effective therapeutic drugs in cases of cancer, liver and infectious diseases. Furthermore, the rising awareness regarding the importance of immunotherapies has increased the need for better therapeutic options and the launch of new products, which is expected to influence market growth in the future. As a result, several research activities have resulted in the development of allogeneic NK cells with maximum therapeutic effects. They also enhance the target and extend the persistence of potent immune cells, which helps create a strong and sustained anti-cancer immune-mediated attack.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Competitive Landscape with Key Players:
- Affimed GmbH
- Bristol-Myers Squibb Company
- Fate Therapeutics
- Fortress Biotech Inc.
- Glycostem Therapeutics
- Innate Pharma S.A.
- Kuur Therapeutics Inc
- Athenex Inc
- Nkarta Inc.
- Takeda Pharmaceutical Company Limited
- Ziopharm Oncology Inc.
Breakup by Therapeutics:
- NK Cell Therapies
- NK Cell Directed Antibodies
Breakup by Application:
- Cancer
- Gastrointestinal Diseases
- Immunoproliferative Disorders
- Others
Breakup by End User:
- Hospitals
- Research Centers and Institutes
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4214&flag=C
Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800
